Repare Therapeutics logo

Repare Therapeutics Share Price Today

(NASDAQ: RPTX)

Repare Therapeutics share price is $1.2 & ₹102.56 as on 18 Apr 2025, 2.30 'hrs' IST

$1.2

0.05

(4.35%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Repare Therapeutics share price in Dollar and Rupees. Guide to invest in Repare Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Repare Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Repare Therapeutics share price movements

  • Today's Low: $1.16
    Today's High: $1.31

    Day's Volatility :11.45%

  • 52 Weeks Low: $0.89
    52 Weeks High: $4.29

    52 Weeks Volatility :79.25%

Repare Therapeutics (RPTX) Returns

PeriodRepare Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-3.23%
-2.8%
0.0%
6 Months
-66.67%
-11.0%
0.0%
1 Year
-61.9%
-1.9%
0.0%
3 Years
-89.79%
-1.5%
-12.9%

Repare Therapeutics (RPTX) Key Statistics

in dollars & INR

Previous Close
$1.15
Open
$1.15
Today's High
$1.31
Today's Low
$1.16
Market Capitalization
$51.0M
Today's Volume
$844.5K
52 Week High
$4.29
52 Week Low
$0.89
Revenue TTM
$53.5M
EBITDA
$-90.2M
Earnings Per Share (EPS)
$-2.09
Profit Margin
-158.37%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-46.63%

How to invest in Repare Therapeutics Stock (RPTX) from India?

It is very easy for Indian residents to invest directly in Repare Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Repare Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Repare Therapeutics or RPTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Repare Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Repare Therapeutics shares which would translate to 0.712 fractional shares of Repare Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Repare Therapeutics, in just a few clicks!

Returns in Repare Therapeutics (RPTX) for Indian investors in Rupees

The Repare Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Repare Therapeutics investment value today

Current value as on today

₹40,436

Returns

₹59,564

(-59.56%)

Returns from Repare Therapeutics Stock

₹61,905 (-61.9%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Repare Therapeutics (RPTX)

25%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Repare Therapeutics Stock from India on INDmoney has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Repare Therapeutics

  • Bvf Inc

    24.31%

  • Blue Owl Capital Holdings LP

    8.10%

  • Orbimed Advisors, LLC

    7.82%

  • Versant Venture Management LLC

    6.23%

  • ARK Investment Management LLC

    4.70%

  • Redmile Group, LLC

    4.51%

Analyst Recommendation on Repare Therapeutics

Rating
Trend

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Repare Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Repare Therapeutics Stock (RPTX)

What analysts predicted

Upside of 441.67%

Target:

$6.50

Current:

$1.20

Insights on Repare Therapeutics Stock (Ticker Symbol: RPTX)

  • Price Movement

    In the last 7 days, RPTX stock has moved up by 27.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 52.40M → 1.07M (in $), with an average decrease of 98.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -34.77M → -28.67M (in $), with an average increase of 10.5% per quarter
  • RPTX vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 139.6%
  • RPTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 119.1%
  • Price to Sales

    ForRPTX every $1 of sales, investors are willing to pay $1.0, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Repare Therapeutics Technicals Summary

Sell

Neutral

Buy

Repare Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Repare Therapeutics (RPTX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Repare Therapeutics Inc logo
7.14%
-66.67%
-61.9%
-89.79%
-96.1%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Repare Therapeutics

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
Organization
Repare Therapeutics
Employees
129
CEO
Dr. Daniel Durocher Ph.D.
Industry
Health Technology

Management People of Repare Therapeutics

NameTitle
Dr. Daniel Durocher Ph.D.
Co-Founder
Dr. Frank Sicheri Ph.D.
Co-Founder
Dr. Agnel Sfeir Ph.D.
Co-Founder
Sandra Alves
Chief Accounting Officer
Dr. Michael Zinda Ph.D.
Executive VP & Chief Scientific Officer
Mr. Daniel Belanger
Executive Vice President of Human Resource
Mr. Philip Herman
Executive VP, Chief Commercial & Portfolio Development Officer

Important FAQs about investing in RPTX Stock from India :

What is Repare Therapeutics share price today?

Repare Therapeutics share price today stands at $1.20, Open: $1.15 ; Previous Close: $1.15 ; High: $1.31 ; Low: $1.16 ; 52 Week High: $4.29 ; 52 Week Low: $0.89.

The stock opens at $1.15, after a previous close of $1.15. The stock reached a daily high of $1.31 and a low of $1.16, with a 52-week high of $4.29 and a 52-week low of $0.89.

Can Indians buy Repare Therapeutics shares?

Yes, Indians can invest in the Repare Therapeutics (RPTX) from India.

With INDmoney, you can buy Repare Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Repare Therapeutics at zero transaction cost.

How can I buy Repare Therapeutics shares from India?

It is very easy to buy Repare Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Repare Therapeutics (RPTX) be purchased?

Yes, you can buy fractional shares of Repare Therapeutics with INDmoney app.

What are the documents required to start investing in Repare Therapeutics stocks?

To start investing in Repare Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Repare Therapeutics Stock (RPTX)?

Today’s highest price of Repare Therapeutics (RPTX) is $1.31.

Today’s lowest price of Repare Therapeutics (RPTX) is $1.16.

What is today's market capitalisation of Repare Therapeutics?

Today's market capitalisation of Repare Therapeutics RPTX is 51.0M

What is the 52 Week High and Low Range of Repare Therapeutics Stock (RPTX)?

  • 52 Week High

    $4.29

  • 52 Week Low

    $0.89

What are the historical returns of Repare Therapeutics (RPTX)?

  • 1 Month Returns

    7.14%

  • 3 Months Returns

    -66.67%

  • 1 Year Returns

    -61.9%

  • 5 Years Returns

    -96.1%

Who is the Chief Executive Officer (CEO) of Repare Therapeutics ?

Dr. Daniel Durocher Ph.D. is the current Chief Executive Officer (CEO) of Repare Therapeutics.